SCHEMBL5696946

SCHEMBL5696946

CC(C)(C)OC(=O)NC[C@@H](SCc1ccccn1)C(=O)N(C#N)C1CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 3/20 0.35
FAP Q12884 1/20 0.35
ACACB O00763 1/20 0.34
ACACA Q13085 1/20 0.34
CTSS P25774 4/20 0.34
CTSK P43235 2/20 0.34
REN P00797 1/20 0.34
CTSD P07339 1/20 0.34
CTSE P14091 1/20 0.34
CTSL P07711 2/20 0.33
CTSB P07858 2/20 0.33
THRB P10828 1/20 0.33
KEAP1 Q14145 1/20 0.33
NFE2L2 Q16236 1/20 0.33
NPC1 O15118 1/20 0.33
MAPT P10636 1/20 0.33
RAB9A P51151 1/20 0.33
MCL1 Q07820 1/20 0.33
ALDH1A1 P00352 2/20 0.32
SYK P43405 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5696941 0.81 PPARG (0.43) CTSSCTSKCTSLCTSBALDH1A1
SCHEMBL6048166 0.71 CTSK (0.38) DPP4CTSSCTSKCTSDCTSL
SCHEMBL5519985 0.71 STS (0.44) THRB
SCHEMBL31758115 0.69 ALDH1A1 (0.45) NPC1MAPTRAB9AALDH1A1SYK
SCHEMBL29611056 0.67 SMN1; SMN2 (0.61) NPC1MAPTRAB9AALDH1A1
SCHEMBL4678395 0.67 SMN1; SMN2 (0.61) NPC1MAPTRAB9AALDH1A1
SCHEMBL5522238 0.67 CTSS (0.60) CTSSCTSKCTSLCTSB
SCHEMBL30992257 0.66 SMN1; SMN2 (0.59) NPC1MAPTRAB9AALDH1A1
SCHEMBL5606156 0.66 CTSK (0.38) DPP4CTSSCTSKCTSLCTSB
SCHEMBL24872785 0.65 ALDH1A1 (0.42) NPC1RAB9AALDH1A1SYKCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1663958-A2 HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2006-06-07 EP disclosed
WO-2005028429-A2 HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2005-03-31 WO disclosed